The prevalence of co-morbid asthma in a New Zealand cycstic fibrosis population

A Bennett; Pip Southwell; Maree Bernoth; K Perrin

The prevalence of co-morbid asthma in a New Zealand cycstic fibrosis population

A Bennett, Pip Southwell, Maree Bernoth, K Perrin

Capital and Coast District Health Board

Research output: Other contribution to conference › Abstract › peer-review

Abstract

Bronchodilators are used internationally for 50–80% of patient swith cystic fibrosis (CF). No published data exists on co-morbid asthma or bronchodilator use in New Zealand (NZ). Bronchodilator responsiveness has been reported in≥50% of patients with CF. Aim: To determine the prevalence of co-morbid asthma in the adult CF population of Wellington, NZ.

Original language	English
Pages	1
Publication status	Published - 2015
Event	Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science Annual Scientific Meeting 2015 - Gold Coast, Australia Duration: 27 Mar 2015 → 01 Apr 2015 https://onlinelibrary.wiley.com/toc/14401843/2015/20/S2 (Abstracts)

Conference

Conference	Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science Annual Scientific Meeting 2015
Country/Territory	Australia
City	Gold Coast
Period	27/03/15 → 01/04/15
Internet address	https://onlinelibrary.wiley.com/toc/14401843/2015/20/S2 (Abstracts)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{a5ea5d2171f140a1b098a7ff6b740f55,

title = "The prevalence of co-morbid asthma in a New Zealand cycstic fibrosis population",

abstract = "Bronchodilators are used internationally for 50–80% of patient swith cystic fibrosis (CF). No published data exists on co-morbid asthma or bronchodilator use in New Zealand (NZ). Bronchodilator responsiveness has been reported in≥50% of patients with CF. Aim: To determine the prevalence of co-morbid asthma in the adult CF population of Wellington, NZ.",

author = "A Bennett and Pip Southwell and Maree Bernoth and K Perrin",

year = "2015",

language = "English",

pages = "1",

note = "Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science Annual Scientific Meeting 2015 ; Conference date: 27-03-2015 Through 01-04-2015",

url = "https://onlinelibrary.wiley.com/toc/14401843/2015/20/S2",

}

The prevalence of co-morbid asthma in a New Zealand cycstic fibrosis population. / Bennett, A; Southwell, Pip; Bernoth, Maree et al.
2015. 1 Abstract from Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science Annual Scientific Meeting 2015, Gold Coast, Queensland, Australia.

Research output: Other contribution to conference › Abstract › peer-review

TY - CONF

T1 - The prevalence of co-morbid asthma in a New Zealand cycstic fibrosis population

AU - Bennett, A

AU - Southwell, Pip

AU - Bernoth, Maree

AU - Perrin, K

PY - 2015

Y1 - 2015

N2 - Bronchodilators are used internationally for 50–80% of patient swith cystic fibrosis (CF). No published data exists on co-morbid asthma or bronchodilator use in New Zealand (NZ). Bronchodilator responsiveness has been reported in≥50% of patients with CF. Aim: To determine the prevalence of co-morbid asthma in the adult CF population of Wellington, NZ.

AB - Bronchodilators are used internationally for 50–80% of patient swith cystic fibrosis (CF). No published data exists on co-morbid asthma or bronchodilator use in New Zealand (NZ). Bronchodilator responsiveness has been reported in≥50% of patients with CF. Aim: To determine the prevalence of co-morbid asthma in the adult CF population of Wellington, NZ.

M3 - Abstract

SP - 1

T2 - Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science Annual Scientific Meeting 2015

Y2 - 27 March 2015 through 1 April 2015

ER -

The prevalence of co-morbid asthma in a New Zealand cycstic fibrosis population

Abstract

Conference

UN SDGs

Fingerprint

Cite this